<DOC>
	<DOCNO>NCT01507896</DOCNO>
	<brief_summary>The purpose study assess hemostatic efficacy safety BAX 326 subject severe ( FIX level &lt; 1 % ) moderately severe ( FIX level 1-2 % ) hemophilia B undergoing major minor elective emergency surgical , dental invasive procedure .</brief_summary>
	<brief_title>BAX 326 Surgery Study Hemophilia B Patients</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<criteria>Main Participant and/or legal representative has/have voluntarily provide sign informed consent . Participant severe ( FIX level &lt; 1 % ) moderately severe ( FIX level 12 % ) hemophilia B ( base one stage activate partial thromboplastin time ( aPTT ) assay ) , test screening central laboratory . Participant require surgery Participant previously treat plasmaderived and/or recombinant FIX concentrate ( ) minimum 150 exposure day Participant evidence history FIX inhibitor Participant immunocompetent evidence CD4 count ≥ 200 cells/mm3 . Participant human immunodeficiency ( HIV ) negative HIV+ viral load &lt; 200 particles/μL ~ &lt; 400,000 copies/mL . Main Participant history FIX inhibitor titer ≥ 0.6 Bethesda Units ( BU ) ( determine Nijmegen modification Bethesda assay assay employ respective local laboratory ) time prior screening . Participant detectable FIX inhibitor screening , titer ≥0.6 Bethesda Units ( BU ) determine Nijmegen modification Bethesda assay central laboratory . Participant history allergic reaction evidence ongoing recent thrombotic disease , fibrinolysis disseminate intravascular coagulation ( DIC ) . Known hypersensitivity hamster proteins recombinant furin . Evidence ongoing recent thrombotic disease , fibrinolysis disseminate intravascular coagulation ( DIC ) . Abnormal renal function Severe chronic liver disease Active hepatic disease ALT AST level &gt; 5 time upper limit normal . Diagnosis iherited acquire hemostatic defect hemophilia B. Platelet count &lt; 100,000/mL .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>